United Therapeutics (STU:UTH) Marketable Securities : €1,340 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is United Therapeutics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. United Therapeutics's Marketable Securities for the quarter that ended in Mar. 2024 was €1,340 Mil.

United Therapeutics's annual Marketable Securities increased from Dec. 2021 (€917 Mil) to Dec. 2022 (€1,772 Mil) but then declined from Dec. 2022 (€1,772 Mil) to Dec. 2023 (€1,638 Mil).

United Therapeutics Marketable Securities Historical Data

The historical data trend for United Therapeutics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Therapeutics Marketable Securities Chart

United Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

672.75

901.16

916.77

1,772.36

1,638.13

United Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															1,587.71	1,487.60	1,656.43	1,638.13	1,339.80

United Therapeutics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

United Therapeutics (STU:UTH) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

United Therapeutics Marketable Securities Related Terms

Thank you for viewing the detailed overview of United Therapeutics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

United Therapeutics (STU:UTH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » United Therapeutics Corp (STU:UTH) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

UTHR:USA

Address

1040 Spring Street, Silver Spring, MD, USA, 20910

Website

https://www.unither.com

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

United Therapeutics (STU:UTH) Headlines

No Headlines